killtoy,
Dilution in an early stage company is not fun. Dilution on steroids, after a massive r/s, is very, very painful.
If ACT is likely to issue massive shares on large exchange then it will happen on the OTC also. I owned a much larger percentage of this company 2 years ago than I do now because of massive dilution...so what is your point? I think this entire post is about the normal BS rs you see with most companies. If the author is putting ACT in that category then so be it. I don't plan on taking the time to respond. I have absolutely no doubt that ACT has cleansed the books and has positioned themselves for a large exchange as they rightfully should do under the circumstances. ACT can either wait for the pps to get to near $4(will be a long wait) or wait a while hoping pps moves to a level they are comfortable with to reverse. It's coming, and you have options to deal with it.
and you said,
"Your example would be 100% on the target if ACTC does not issues any new shares after the R/S"
So, what company doesn't issue more shares? ..I fail to see your point. And if we stay on OTC we have no more dilution? lol
